CompletedPhase 1
A Phase 1b Study to Characterize the Safety and Tolerability of TEV-53408 in Adults with Celiac Disease
Key facts
- Who runs it
- Teva Branded Pharmaceutical Products R&D LLC
- Where
- Finland2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 6 people enrolled
- Started
- 15 Mar 2024
- Ended
- 8 Oct 2025
- Type of study
- Interventional
- Record updated
- 10 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Record updated
- 10 September 2025